Watch this on-demand EMJ webinar focused on neoadjuvant treatments in breast cancer. Our expert guest Lubna N. Chaudhary, Associate Professor of Medicine, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, USA, speaks about current data and ongoing research on neoadjuvant treatments for different breast cancer subtypes.
Topics covered include:
- Indications of neoadjuvant chemotherapy and current standard regimens
- Indications of neoadjuvant endocrine therapy
- Ongoing research to understand tumour responses and endocrine resistance mechanisms
Chaudhary’s clinical research focuses on understanding breast cancer tumour biology, mechanisms of endocrine resistance, and developmental therapeutics for patients with breast cancer. She is also principal investigator of two investigator-initiated clinical trials: the first assesses endocrine resistance pathways with neoadjuvant endocrine therapy and the second explores the breast tumour molecular changes with immunotherapy.
